Skip Ribbon Commands
Skip to main content
Menu
Home > Patient Care > Medicine > Anti-Tumor Necrosis Factor alpha > What Anti-Tumor Necrosis Factor alpha treats

Anti-Tumor Necrosis Factor alpha

Drug Class: Commonly Known As: Category:

Anti-Tumor Necrosis Factor alpha - What is it for

 Anti-Tumor Necrosis Factor alpha (anti-TNFα) belongs to a class of medications called biologics or more specifically, biological disease modifying anti-rheumatic drugs (bDMARD). 

Biologics work by blocking targeted parts of the immune system that cause inflammation in the body. 

Anti-TNFα targets and blocks the effect of TNF. This reduces inflammation and flares, improves symptoms and quality of life, and prevents disease progression.
There are many anti-TNFα drugs available including adalimumab, certolizumab, etanercept, golimumab and infliximab. It may be used alone (monotherapy) or together with other DMARDs. 
Biologics are more costly compared to conventional DMARDs. Your doctor may discuss with you if there is a biosimilar (non-branded version of the original biologic) which works the same way as biologics at a more affordable cost.
  • Updated on 10/31/2023 12:00:00 AM
  • Article contributed by PSS National Medication Information Workgroup PSS National Medication Information Workgroup
The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth

Find Your Medicines

  • medication icon

    Learn about use of medicines, side effects and proper storage.

HealthCareProfessionalsSignUps

​

​

About Us

Patient Care

Research

Education

Careers

Giving

SingHealth
SingHealth Duke-NUS
 Changi General Hospital, 2 Simei Street 3,
    Singapore 529889

  +65 6788 8833
© 2024 SingHealth Group. All Rights Reserved.

Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.